You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page

No matches

Rhinology

On demand events

Anosmia Awareness Day 2024

Explore our educational resources about loss of smell and the role of type 2 inflammation in CRSwNP, featuring expert insights from Prof. Wytske Fokkens, Dr. Stella Lee, and Prof. Joaquim Mullol, among others.

MD, PhD

Joaquim Mullol +2 more

On demand materials

Defining Mechanisms of Anosmia in CRSwNP

Rhinology

2 min

expert video

Defining Mechanisms of Anosmia in CRSwNP

Rhinology

15 min

Podcast

ADVENT On Air | Loss of Smell in CRSwNP Patients

Description

February 27 is Anosmia Awareness Day. Anosmia, which can refer to partial or full loss of smell, is a symptom in up to 90% of people with uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP) and is one of the symptoms most associated with decreased quality of life, according to those who experience it.^1,2 Even with treatment, altered sense of smell is one of the most recalcitrant symptoms of CRSwNP.²

Learn more about altered sense of smell in CRSwNP and type 2 inflammation, which is associated with disease pathology in up to 87% of people with CRSwNP, by exploring the resources available at ADVENTprogram.com.³

_1._{Fokkens WJ, et al.}_Rhinology_{. 2020;Suppl. 29:1-464.}_2._{Mullol J, et al.}_{J Allergy Clin Immunol Pract}_{. 2022;10(4):1086-1095.e5.}_3._{Stevens WW, et al.}_{J Allergy Clin Immunol Pract}_{. 2019;7(8):2812-2820.e3.}

About these experts

Rhinology

MD, PhD

Joaquim Mullol

Director of the Rhinology Unit & Smell Clinic, Department of Otorhinolaryngology | Hospital Clinic, Barcelona, Spain; Professor of Research and Head of the Laboratory of Clinical and Experimental Respiratory Immunoallergy | August Pi i Sunyer Biomedical Research Institute, Barcelona, Spain | Head of Research Group at Biomedical Research Network on Respiratory Diseases (CIBERES) | Carlos III Institute of Health, Barcelona, Spain

Rhinology

Stella Lee

Chief of Rhinology at Brigham and Women’s Hospital | Harvard Medical School, Boston, United States

Rhinology

MD, PhD

Wytske Fokkens

Professor in the Department of Otorhinolaryngology | Academic Medical Center, Amsterdam, Netherlands; Director | European Forum for Research and Education in Allergy and Airway Diseases (EUFOREA)

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: DenmarkChange country/region